Exploring the effects of COVID-19 on patients with diabetes, we found that the novel coronavirus damages islet β cells, leading to reduced insulin secretion, triggering cytokine-induced insulin resistance, and making blood glucose control more difficult. The gene discussed is INS; the disease is COVID-19.